Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion

Kye Min Kim, Byung Moon Choi, Si Won Park, Soo Han Lee, Lane V. Christensen, Jiaye Zhou, Byung Hoon Yoo, Hye Won Shin, Kyun Seop Bae, Steven E. Kern, Sung Hong Kang, Gyu Jeong Noh

    Research output: Contribution to journalArticlepeer-review

    64 Citations (Scopus)

    Abstract

    BACKGROUND: The aim of this trial was to evaluate the induction and recovery characteristics of microemulsion propofol (Aquafol; Daewon Pharmaceutical Co., Ltd., Seoul, Korea). Pharmacokinetics, pharmacodynamics, and safety profile were investigated. Lipid emulsion propofol (Diprivan®; AstraZeneca, London, United Kingdom) was used as a comparator. METHODS: Thirty-one healthy volunteers aged 20-79 yr were given an intravenous bolus of propofol 2 mg/kg, followed by variable rate infusion for 60 min. Each volunteer was studied twice with different formulations at an interval of 1 week. Arterial concentrations of propofol were measured, and Bispectral Index was used as a surrogate measure of propofol effect. The induction and recovery characteristics including bioequivalence were evaluated by noncompartmental analysis. The pharmacokinetics and pharmacodynamics were investigated using a population approach with mixed effects modeling. The rate, severity, and causal relation of adverse events were analyzed. RESULTS: Both formulations were bioequivalent. The observed time to peak effect after a bolus of both formulations was 1.5 min. Plasma concentration of propofol at loss of consciousness, time to loss of consciousness after a bolus, and time to recovery of consciousness after discontinuation of infusion did not show significant differences. The population pharmacokinetics and pharmacodynamics revealed a variety of differences between two formulations. Aquafol showed similar safety profile to Diprivan®. CONCLUSIONS: The efficacy and safety of Aquafol were not different from those of Diprivan® within the dose range in this study.

    Original languageEnglish
    Pages (from-to)924-934
    Number of pages11
    JournalAnesthesiology
    Volume106
    Issue number5
    DOIs
    Publication statusPublished - 2007 May

    ASJC Scopus subject areas

    • Anesthesiology and Pain Medicine

    Fingerprint

    Dive into the research topics of 'Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion'. Together they form a unique fingerprint.

    Cite this